Financhill
Back

Illumina Quote, Financials, Valuation and Earnings

Illumina Price Quote

$116.99
+0.30 (+0.26%)
(Updated: April 19, 2024 at 2:50 PM ET)

Illumina Key Stats

Sell
30
Illumina (ILMN) is a Sell

Day range:
$115.73 - $119.18
52-week range:
$89.00 - $229.58
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
4.09
P/B ratio:
3.23%

Volume:
1.6M
Avg. volume:
1.6M
1-year change:
-48.88%
Market cap:
$18.5B
Revenue:
$4.5B
EPS:
$-7.34

How Much Does Illumina Make?

  • How Much Are Illumina's Sales Annually?
    ILMN Revenues are $4.5B
  • How Much Profit Does Illumina's Make A Year?
    ILMN net income is -$1.2B

Is Illumina Growing As A Company?

  • What Is Illumina's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.04%
  • What Is Illumina's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Illumina Stock Price Performance

  • Did Illumina Stock Go Up Last Month?
    Illumina share price went down by -10.34% last month
  • Did ILMN's Share Price Rise Over The Last Year?
    ILMN share price fell by -48.88% over the past 1 year

What Is Illumina 52-Week High & Low?

  • What Is Illumina’s 52-Week High Share Price?
    Illumina has traded as high as $229.58 over the past 52 weeks
  • What Is Illumina’s 52-Week Low Share Price?
    Illumina has traded as low as $89.00 over the past 52 weeks

Illumina Price To Free Cash Flow

  • Is Illumina Stock Overvalued?
    Illumina is trading at a price to free cash flow ratio of 65.38
  • Is Illumina Stock Undervalued?
    Illumina EV to Free Cash Flow ratio is 67.29
  • What Is Illumina’s Price Earnings Growth Ratio?
    ILMN PEG ratio is 0.00
  • Is Illumina Trading At A Premium To Earnings?
    Illumina EV to EBIT ratio is 0.00

Is It Risky To Buy Illumina?

  • How Much Debt Does Illumina Have?
    Total long term debt quarterly is $1.5B
  • How Much Cash Does Illumina Have?
    Cash and short term investments quarterly total is $1.1B
  • What Is Illumina’s Book Value Per Share?
    Book value per share is 36.13

Is Illumina Cash Flow Positive?

  • What Is ILMN Cash Flow From Operations?
    Cash flow from operations (TTM) is $478M
  • What Is Illumina’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$1.2B
  • What Is Illumina’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$231M

Illumina Return On Invested Capital

  • Is Management Doing A Good Job?
    ILMN return on invested capital is -13.92%
  • What Is Illumina Return On Assets?
    ROA measures how assets are converting to revenues and is -10.34%
  • What Is ILMN Return On Equity?
    ROE is a measure of profitability and is -18.42%

Illumina Earnings Date & Stock Price

  • What Is Illumina's Stock Price Today?
    A single share of ILMN can be purchased today for 116.69
  • What Is Illumina’s Stock Symbol?
    Illumina trades on the S&P500 under the ticker symbol: ILMN
  • When Is Illumina’s Next Earnings Date?
    The next quarterly earnings date for Illumina is scheduled on May 2, 2024
  • When Is ILMN's next ex-dividend date?
    Illumina's next ex-dividend date is May 21, 2020
  • How To Buy Illumina Stock?
    You can buy Illumina shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Illumina Competitors

  • Who Are Illumina's Competitors?
    Below is a list of companies who compete with Illumina or are related in some way:
    • Castle Biosciences Inc (CSTL)
    • Quest Diagnostics Inc (DGX)
    • Exact Sciences Corp (EXAS)
    • Guardant Health Inc (GH)
    • Natera Inc (NTRA)

Illumina Dividend Yield

Data Unavailable

Illumina Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 17.58%
Revenue: 3.6% 1.39%

Analyst Recommendations

Buy Recommendations: 6
Hold Recommendations: 12
Sell Recommendations: 0
Price Target: 160.67
Upside from Last Price: 37.69%

Major Shareholders

  • How many ILMN shares are owned by institutional investors?
    221.4M ILMN shares are owned by institutional investors
  • How many ILMN shares are owned by insiders?
    3.3M ILMN shares are owned by insiders